Literature DB >> 23267299

Association of MTHFR C677T and A1298C gene polymorphisms with hypertension.

Abdullah Alghasham1, Ahmad A Settin, Ahmad Ali, Moataz Dowaidar, Hisham Ismail.   

Abstract

OBJECTIVES: To check for the association of genetic polymorphisms related to the methylenetetrahydrofolate reductase (MTHFR) gene namely C677T and A1298C with hypertension in Saudi affected subjects from Qassim region. SUBJECTS AND METHODS: Participants included 123 Saudi hypertensive cases (83 males and 40 females) in addition to 250 (142 males and 108 females) unrelated healthy controls from the same locality. Their age mean ±SD was 50.93 ± 15.43 years. For all subjects, DNA was extracted followed by real-time PCR amplifications for characterization of genotypes and alleles related to MTHFR C677T and A1298C gene polymorphisms
RESULTS: Total cases showed significantly higher carriage rate for the mutant allele 677T compared to controls (40.7% vs. 26%, OR=1.9, 95% CI= 1.2-3.1) with a lower frequency of the wild type 677CC genotype (59.3% vs. 74%, p=0.004). The same was observed among cases-subgroups of hypertension associated with obesity with a notably higher odds ratio (OR=2.6, 95% CI=1.3-5.01, p=0.004). Total cases showed also significantly higher frequency of mutant 1298 C allele carriage rate compared to controls (59.3% vs. 42.4%, OR=1.98, 95% CI= 1.3-3.1) with a lower frequency of the normal AA genotype (40.7% vs. 57.6%, p=0.003). The same was observed among cases-subgroups of hypertension associated with both diabetes and obesity and among cases of hypertension with obesity, also with higher odds ratio (OR=2.6 and 2.2 respectively).
CONCLUSION: This work showed that genetic polymorphisms related to the MTHFR gene are associated with the risk of hypertension particularly when accompanied with obesity and diabetes among Saudi subjects.

Entities:  

Keywords:  Genetic polymorphisms; Methylenetetrahydrofolate reductase; Saudi; hypertension

Year:  2012        PMID: 23267299      PMCID: PMC3523778          DOI: 10.12816/0005968

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN: 1658-3639


  35 in total

1.  A method for homogeneous color-compensated genotyping of factor V (G1691A) and methylenetetrahydrofolate reductase (C677T) mutations using real-time multiplex fluorescence PCR.

Authors:  N von Ahsen; M Oellerich; E Schütz
Journal:  Clin Biochem       Date:  2000-10       Impact factor: 3.281

2.  Evaluation of candidate genes in case-control studies: a statistical method to account for related subjects.

Authors:  S L Slager; D J Schaid
Journal:  Am J Hum Genet       Date:  2001-05-15       Impact factor: 11.025

Review 3.  The changing concept of epigenetics.

Authors:  Eva Jablonka; Marion J Lamb
Journal:  Ann N Y Acad Sci       Date:  2002-12       Impact factor: 5.691

4.  Blood pressure pattern in Saudi population of Gassim.

Authors:  M A Soyannwo; N Y Kurashi; M Gadallah; J Hams; O el-Essawi; N A Khan; R G Singh; A Alamri; T H Beyari
Journal:  Afr J Med Med Sci       Date:  1998 Mar-Jun

5.  The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine.

Authors:  I S Weisberg; P F Jacques; J Selhub; A G Bostom; Z Chen; R Curtis Ellison; J H Eckfeldt; R Rozen
Journal:  Atherosclerosis       Date:  2001-06       Impact factor: 5.162

6.  Methylenetetrahydrofolate reductase polymorphism, type II diabetes mellitus, coronary artery disease, and essential hypertension in the Czech population.

Authors:  P Benes; K Kanková; J Muzík; L Groch; J Benedík; L Elbl; L Izakovicová-Hollá; A Vasků; V Znojil; J Vácha
Journal:  Mol Genet Metab       Date:  2001-06       Impact factor: 4.797

7.  Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus.

Authors:  S P Stabler; R Estacio; B W Jeffers; J A Cohen; R H Allen; R W Schrier
Journal:  Metabolism       Date:  1999-09       Impact factor: 8.694

8.  The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians.

Authors:  Stephanie Heux; Fabien Morin; Rod A Lea; Micky Ovcaric; Lofti Tajouri; Lyn R Griffiths
Journal:  Hypertens Res       Date:  2004-09       Impact factor: 3.872

9.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.

Authors:  P Frosst; H J Blom; R Milos; P Goyette; C A Sheppard; R G Matthews; G J Boers; M den Heijer; L A Kluijtmans; L P van den Heuvel
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

10.  Total plasma homocysteine is associated with hypertension in Type I diabetic patients.

Authors:  S Neugebauer; L Tarnow; C Stehouwer; T Teerlink; T Baba; T Watanabe; H-H Parving
Journal:  Diabetologia       Date:  2002-08-08       Impact factor: 10.122

View more
  15 in total

1.  Association between Hcy levels and the CBS844ins68 and MTHFR C677T polymorphisms with essential hypertension.

Authors:  Weijuan Cai; Liang Yin; Fang Yang; Lei Zhang; Jiang Cheng
Journal:  Biomed Rep       Date:  2014-09-05

2.  Association of a methylene tetrahydrofolate reductase C677T polymorphism with several blood chemical levels in a Chinese population.

Authors:  Can Wen; Jiao-Feng Lv; Ling Wang; Wei-Feng Zhu; Fu-Sheng Wan; Xiao-Zhong Wang
Journal:  Genet Test Mol Biomarkers       Date:  2015-01

3.  Associations Between Genetic Variants of the Natriuretic Peptide System and Blood Pressure Response to Dietary Sodium Intervention: The GenSalt Study.

Authors:  Shufeng Chen; Jianfeng Huang; Qi Zhao; Jing Chen; Cashell E Jaquish; Jiang He; Xiangfeng Lu; Xueli Yang; Charles C Gu; James E Hixson; Fangchao Liu; Treva K Rice; Jie Cao; Jichun Chen; Dongfeng Gu
Journal:  Am J Hypertens       Date:  2015-07-29       Impact factor: 2.689

4.  Signaling pathway genes for blood pressure, folate and cholesterol levels among hypertensives: an epistasis analysis.

Authors:  L K Wei; S Menon; L R Griffiths; S H Gan
Journal:  J Hum Hypertens       Date:  2014-07-24       Impact factor: 3.012

Review 5.  Associations of MTHFR gene polymorphisms with hypertension and hypertension in pregnancy: a meta-analysis from 114 studies with 15411 cases and 21970 controls.

Authors:  Boyi Yang; Shujun Fan; Xueyuan Zhi; Yongfang Li; Yuyan Liu; Da Wang; Miao He; Yongyong Hou; Quanmei Zheng; Guifan Sun
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

6.  High Incidence of ACE/PAI-1 in Association to a Spectrum of Other Polymorphic Cardiovascular Genes Involving PBMCs Proinflammatory Cytokines in Hypertensive Hypercholesterolemic Patients: Reversibility with a Combination of ACE Inhibitor and Statin.

Authors:  Jeanne d'Arc AlBacha; Mira Khoury; Charbel Mouawad; Katia Haddad; Samar Hamoui; Albert Azar; Ziad Fajloun; Nehman Makdissy
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

7.  Relationship between MTHFR C677T and A1298C gene polymorphisms and complications of type 2 diabetes mellitus in an Emirati population.

Authors:  Sarah W El Hajj Chehadeh; Herbert F Jelinek; Wael A Al Mahmeed; Guan K Tay; Unini O Odama; Gehad E B Elghazali; Habiba S Al Safar
Journal:  Meta Gene       Date:  2016-04-17

8.  Association of methylenetetrahydrofolate reductase gene (C677T) with the risk of hypertension in Morocco.

Authors:  Sanaa Nassereddine; Yaya Kassogue; Farah Korchi; Rachida Habbal; Sellama Nadifi
Journal:  BMC Res Notes       Date:  2015-12-12

Review 9.  Assessment of the environmental and genetic factors influencing prevalence of metabolic syndrome in Saudi Arabia.

Authors:  Ibrahim M Gosadi
Journal:  Saudi Med J       Date:  2016-01       Impact factor: 1.484

10.  Systemic and Local Factors' Influence on the Topological Differences in Deep Vein Thrombosis.

Authors:  Ştefan Cristian Vesa; Romeo Chira; Sonia Irina Vlaicu; Sergiu Pașca; Sorin Crișan; Adrian Trifa; Anca Dana Buzoianu
Journal:  Medicina (Kaunas)       Date:  2019-10-16       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.